Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins.

[1]  J. Mehta,et al.  Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. , 1995, The Journal of laboratory and clinical medicine.

[2]  E. Leung,et al.  Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  H. Vapaatalo,et al.  Plasma ANP and cyclic GMP after physical exercise in patients with mitral valve disease and in healthy subjects. , 1993, International journal of cardiology.

[4]  H. Vapaatalo,et al.  Inhibition by nitric oxide‐donors of human polymorphonuclear leucocyte functions , 1993, British journal of pharmacology.

[5]  B. Brüne,et al.  Efflux of cyclic GMP from activated human platelets. , 1993, Molecular pharmacology.

[6]  U. Walter,et al.  Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Kelm,et al.  Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. , 1991, Biochemical and biophysical research communications.

[8]  M. Houslay,et al.  Desensitization of atriopeptin stimulated accumulation and extrusion of cyclic GMP from a kidney epithelial cell line (MDCK). , 1991, Biochemical pharmacology.

[9]  J. Vane,et al.  The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO‐donors , 1990, British journal of pharmacology.

[10]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Schrader,et al.  Control of coronary vascular tone by nitric oxide. , 1990, Circulation research.

[12]  S. Macneil,et al.  Cyclic GMP release and vasodilatation induced by EDRF and atrial natriuretic factor in the isolated perfused kidney of the rat , 1990, British journal of pharmacology.

[13]  P. Hamet,et al.  Atrial natriuretic factor-induced egression of cyclic guanosine 3':5'-monophosphate in cultured vascular smooth muscle and endothelial cells. , 1989, The Journal of biological chemistry.

[14]  V. Schini,et al.  Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta , 1989, British journal of pharmacology.

[15]  S Moncada,et al.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.

[16]  M. Tjörnhammar,et al.  Efflux of cyclic guanosine 3′,5′-monophosphate from cerebellar slices stimulated by l-glutamate or high K+ or N-methyl-N′-nitro-N-nitrosoguanidine , 1986, Neuroscience Letters.

[17]  E. Schiffrin,et al.  Cyclic GMP as mediator and biological marker of atrial natriuretic factor. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[18]  R. Gerzer,et al.  Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man. , 1985, The Journal of clinical endocrinology and metabolism.

[19]  L. Brunton,et al.  Prostaglandin A1 metabolism and inhibition of cyclic AMP extrusion by avian erythrocytes. , 1985, The Journal of biological chemistry.

[20]  H. Fukuzaki,et al.  Inhibitory action of guanosine 3',5'-monophosphate on thrombin-induced calcium mobilization in human platelets. , 1984, Thrombosis research.

[21]  M. Tjörnhammar,et al.  Cyclic GMP efflux from liver slices. , 1983, The Journal of biological chemistry.

[22]  S. Moncada,et al.  An improved method for washing of human platelets with prostacyclin. , 1983, Thrombosis research.

[23]  J E Gander,et al.  18O labeling of adenine nucleotide alpha-phosphoryls in platelets. Contribution by phosphodiesterase-catalyzed hydrolysis of cAMP. , 1983, The Journal of biological chemistry.

[24]  L. Ignarro,et al.  Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. , 1981, Blood.

[25]  L. Brunton,et al.  Extrusion of cyclic AMP from pigeon erythrocytes. , 1979, The Journal of biological chemistry.

[26]  C. Gagnon,et al.  REGULATION OF GUANOSINE 3′,5′ CYCLIC MONOPHOSPHATE IN THE RAT PINEAL AND POSTERIOR PITUITARY GLANDS , 1978, Journal of neurochemistry.

[27]  P. Greengard,et al.  Advances in Cyclic Nucleotide Research , 1973 .

[28]  W. K. Sonnenburg,et al.  Cyclic GMP and regulation of cyclic nucleotide hydrolysis. , 1994, Advances in pharmacology.

[29]  R. Gerzer,et al.  Cyclic GMP in cell function. , 1988, Advances in second messenger and phosphoprotein research.

[30]  Brunton Ll,et al.  Export of cyclic AMP by mammalian reticulocytes. , 1980 .